Cargando…

Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial

BACKGROUND: There are scanty data to apply radial extracorporeal shock wave therapy (rESWT) on the acupuncture points in the lower abdomen to reduce the menstrual pain. This trial aimed to test the rESWT safety and efficacy for treating primary dysmenorrhea (PD). METHODS: Forty-four young-women with...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Ruirui, Yang, Jian, Wang, Renwei, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870246/
https://www.ncbi.nlm.nih.gov/pubmed/33592837
http://dx.doi.org/10.1097/MD.0000000000023798
_version_ 1783648779528830976
author Xing, Ruirui
Yang, Jian
Wang, Renwei
Wang, Yan
author_facet Xing, Ruirui
Yang, Jian
Wang, Renwei
Wang, Yan
author_sort Xing, Ruirui
collection PubMed
description BACKGROUND: There are scanty data to apply radial extracorporeal shock wave therapy (rESWT) on the acupuncture points in the lower abdomen to reduce the menstrual pain. This trial aimed to test the rESWT safety and efficacy for treating primary dysmenorrhea (PD). METHODS: Forty-four young-women with PD were randomly assigned to one of the three groups: to receive rESWT on the acupuncture points during the follicular phase (Group A, n = 15) or during the luteal phase (Group B, n = 14), or to apply heat patch to the acupuncture points during the follicular phase as the control (Group C, n = 15) over three menstrual cycles. The pain severity (using 0-to-10 visual analog scale), the pain duration (hours), plasma PGF(2α) prostaglandin F2alpha and prostaglandin E2 (PGE(2)), self-rating anxiety scale and menstrual blood loss were assessed before and after interventions. RESULTS: The pain severity and duration significantly decreased in all groups after interventions. Although the reduced pain duration was not different among the groups, the reduced pain severity was more significant (P = .003) in Groups A (−53.8 ± 33.7%) and B (−59.3 ± 36.7%) than in Group C (−18.7 ± 27.1%). The rESWT intervention did not change plasma prostaglandins in Group A, although there was a decreased prostaglandin F2alpha (−20.5 ± 32.9%) in Group B or a decreased PGE(2) (-18.9 ± 17.8%) in Group C. The anxiety level showed no change after intervention. The menstrual blood volume reduced slightly after intervention and the change of menstrual blood loss in Group B was significant (P = .038). CONCLUSION: The rESWT applications on the abdominal acupuncture points safely and effectively reduced the menstrual pain, which was not associated with the prostaglandin changes. The rESWT-reduced pain seemed equally effective with the intervention applied during the follicular phase or luteal phase of the menstrual cycle. Heat patch placed on the abdominal acupuncture points also reduced the pain severity and duration, indicating that the improved blood flow could effectively alleviate the menstrual pain with PD. The changes in anxiety level and menstrual blood loss were slight after intervention.
format Online
Article
Text
id pubmed-7870246
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78702462021-02-10 Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial Xing, Ruirui Yang, Jian Wang, Renwei Wang, Yan Medicine (Baltimore) 3800 BACKGROUND: There are scanty data to apply radial extracorporeal shock wave therapy (rESWT) on the acupuncture points in the lower abdomen to reduce the menstrual pain. This trial aimed to test the rESWT safety and efficacy for treating primary dysmenorrhea (PD). METHODS: Forty-four young-women with PD were randomly assigned to one of the three groups: to receive rESWT on the acupuncture points during the follicular phase (Group A, n = 15) or during the luteal phase (Group B, n = 14), or to apply heat patch to the acupuncture points during the follicular phase as the control (Group C, n = 15) over three menstrual cycles. The pain severity (using 0-to-10 visual analog scale), the pain duration (hours), plasma PGF(2α) prostaglandin F2alpha and prostaglandin E2 (PGE(2)), self-rating anxiety scale and menstrual blood loss were assessed before and after interventions. RESULTS: The pain severity and duration significantly decreased in all groups after interventions. Although the reduced pain duration was not different among the groups, the reduced pain severity was more significant (P = .003) in Groups A (−53.8 ± 33.7%) and B (−59.3 ± 36.7%) than in Group C (−18.7 ± 27.1%). The rESWT intervention did not change plasma prostaglandins in Group A, although there was a decreased prostaglandin F2alpha (−20.5 ± 32.9%) in Group B or a decreased PGE(2) (-18.9 ± 17.8%) in Group C. The anxiety level showed no change after intervention. The menstrual blood volume reduced slightly after intervention and the change of menstrual blood loss in Group B was significant (P = .038). CONCLUSION: The rESWT applications on the abdominal acupuncture points safely and effectively reduced the menstrual pain, which was not associated with the prostaglandin changes. The rESWT-reduced pain seemed equally effective with the intervention applied during the follicular phase or luteal phase of the menstrual cycle. Heat patch placed on the abdominal acupuncture points also reduced the pain severity and duration, indicating that the improved blood flow could effectively alleviate the menstrual pain with PD. The changes in anxiety level and menstrual blood loss were slight after intervention. Lippincott Williams & Wilkins 2021-02-05 /pmc/articles/PMC7870246/ /pubmed/33592837 http://dx.doi.org/10.1097/MD.0000000000023798 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Xing, Ruirui
Yang, Jian
Wang, Renwei
Wang, Yan
Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial
title Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial
title_full Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial
title_fullStr Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial
title_full_unstemmed Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial
title_short Extracorporeal shock wave therapy for treating primary dysmenorrhea: A randomized controlled trial
title_sort extracorporeal shock wave therapy for treating primary dysmenorrhea: a randomized controlled trial
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870246/
https://www.ncbi.nlm.nih.gov/pubmed/33592837
http://dx.doi.org/10.1097/MD.0000000000023798
work_keys_str_mv AT xingruirui extracorporealshockwavetherapyfortreatingprimarydysmenorrheaarandomizedcontrolledtrial
AT yangjian extracorporealshockwavetherapyfortreatingprimarydysmenorrheaarandomizedcontrolledtrial
AT wangrenwei extracorporealshockwavetherapyfortreatingprimarydysmenorrheaarandomizedcontrolledtrial
AT wangyan extracorporealshockwavetherapyfortreatingprimarydysmenorrheaarandomizedcontrolledtrial